Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women
Clinical trial NCT07211152 · RECRUITING
Trial details
- NCT number
- NCT07211152
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-13
- Primary completion
- 2026-03-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.